Mobile

A study in people with Cystic Fibrosis ( a rare hereditary pulmonary disease) to assess the efficacy and safety of a combination of two experimental drugs Uno studio condotto in pazienti con fib...

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-003989-40

A study in people with Cystic Fibrosis ( a rare hereditary pulmonary disease) to assess the efficacy and safety of a combination of two experimental drugs Uno studio condotto in pazienti con fibrosi cistica (una rara malattia ereditaria polmonare) per valutare l'efficacia e la sicurezza di una combinazione di due farmaci sperimentali

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the efficacy of lumacaftor in combination with ivacaftor through Week 24 in subjects with Cystic Fibrosis who are homozygous for the F508del-CFTR mutation Valutazione dell'efficacia di lumacaftor in associazione con ivacaftor alla settimana 24 in soggetti affetti da fibrosi cistica (FC), omozigoti per la mutazione F508del CFTR

Critère d'inclusion

  • Cystic fibrosis in patients homozygous for the F508del-CFTR Mutation,Fibrosi cistica in pazienti omozigoti per la mutazione F508del-CFTR

Liens